Pharmacokinetics and Excretion Studies on CDRI-85/92, an Antiulcer Proton Pump Inhibitor

CDRI 85/92 is an antiulcer pharmacophore and a proton pump inhibitor, which is in an advanced stage of preclinical trials. In view of its importance, pharmacokinetic and excretion were studied in Sprague Dawley rats after administering 20 mg/kg oral and intravenous doses. The compound was detectable...

Descripción completa

Detalles Bibliográficos
Autor principal: Srivastava, Pratima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Österreichische Apotheker-Verlagsgesellschaft 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293351/
https://www.ncbi.nlm.nih.gov/pubmed/22396912
http://dx.doi.org/10.3797/scipharm.1111-05

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293351/
https://www.ncbi.nlm.nih.gov/pubmed/22396912
http://dx.doi.org/10.3797/scipharm.1111-05

Ejemplares similares